0,683  0,009  Sensitization
0,649  0,018  GST A substrate
0,636  0,009  Cardiovascular analeptic
0,624  0,014  Antineoplastic (ovarian cancer)
0,565  0,006  Carcinogenic, group 3
0,582  0,025  Antineoplastic (solid tumors)
0,558  0,009  Antineoplastic (osteosarcoma)
0,553  0,014  Ulceration
0,550  0,011  FMO1 substrate
0,532  0,006  Antineoplastic (squamous cell carcinoma)
0,529  0,012  Eye irritation, high
0,536  0,026  Prostate cancer treatment
0,546  0,038  Antineoplastic (lung cancer)
0,547  0,045  Caspase 9 stimulant
0,527  0,026  Immunosuppressant
0,477  0,006  Alpha-N-acetylglucosaminidase inhibitor
0,499  0,032  Teratogen
0,471  0,007  Contraceptive
0,514  0,051  Antineoplastic (breast cancer)
0,524  0,067  Apoptosis agonist
0,492  0,037  Antineoplastic (colorectal cancer)
0,463  0,010  Antineoplastic (carcinoma)
0,483  0,033  Embryotoxic
0,462  0,016  Antimitotic
0,476  0,037  Antineoplastic (colon cancer)
0,464  0,026  Analeptic
0,470  0,033  Respiratory analeptic
0,480  0,043  Antileukemic
0,461  0,027  Antineoplastic (cervical cancer)
0,437  0,003  Mineralocorticoid receptor antagonist
0,432  0,005  Topoisomerase I inhibitor
0,459  0,038  GABA C receptor rho-3 antagonist
0,463  0,046  5 Hydroxytryptamine release inhibitor
0,432  0,015  Calcium channel activator
0,421  0,007  Protein kinase stimulant
0,431  0,017  Antineoplastic (endocrine cancer)
0,436  0,029  Carcinogenic
0,417  0,009  GST M1-1 substrate
0,406  0,005  Carcinogenic, group 1
0,406  0,007  Sepsis treatment
0,415  0,023  Hypolipemic
0,419  0,034  Antineoplastic (pancreatic cancer)
0,397  0,018  Flavin-containing monooxygenase substrate
0,395  0,017  Skin irritative effect
0,413  0,036  Lipoprotein disorders treatment
0,385  0,010  Pneumotoxic
0,428  0,055  CYP3A4 substrate
0,380  0,010  Lipocortins synthesis antagonist
0,374  0,007  Neurotrophic factor enhancer
0,377  0,011  Tyrosine 3 hydroxylase inhibitor
0,390  0,025  Antineoplastic (liver cancer)
0,394  0,028  Antipyretic
0,388  0,029  Tumour necrosis factor alpha release inhibitor
0,431  0,075  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,410  0,060  CYP2C9 substrate
0,383  0,040  CTGF expression inhibitor
0,364  0,022  5 Hydroxytryptamine uptake stimulant
0,411  0,070  Histamine release inhibitor
0,410  0,072  Antibacterial
0,366  0,030  Antiparasitic
0,339  0,007  GABA C receptor agonist
0,336  0,008  Carcinogenic, group 2B
0,378  0,050  Aldehyde oxidase inhibitor
0,330  0,004  GABA C receptor antagonist
0,356  0,031  Antineoplastic (small cell lung cancer)
0,326  0,004  GABA C receptor rho-2 antagonist
0,337  0,017  VCAM1 expression inhibitor
0,372  0,052  5 Hydroxytryptamine release stimulant
0,353  0,034  Heart failure treatment
0,348  0,031  DNA synthesis inhibitor
0,396  0,079  TNF expression inhibitor
0,355  0,039  Radiosensitizer
0,382  0,072  CYP2C19 inhibitor
0,300  0,003  Antineoplastic alkaloid
0,315  0,020  Diuretic
0,337  0,044  Cytostatic
0,419  0,128  Antiinflammatory
0,330  0,040  Mutagenic
0,335  0,045  DNA damaging
0,294  0,005  Phosphofructokinase-1 inhibitor
0,319  0,031  Abortion inducer
0,290  0,003  GST T1-1 substrate
0,305  0,019  Acaricide
0,334  0,050  Hypoxia-inducible factor 1 alpha inhibitor
0,333  0,049  UGT2B4 substrate
0,346  0,063  ICAM1 expression inhibitor
0,327  0,047  Cytotoxic
0,305  0,027  Non-steroidal antiinflammatory agent
0,286  0,009  Excitatory amino acid transporter EAAC1 inhibitor
0,327  0,050  Antineoplastic (multiple myeloma)
0,312  0,037  Cyclic AMP phosphodiesterase inhibitor
0,309  0,036  Peroxidase inhibitor
0,290  0,016  Interleukin 6 antagonist
0,335  0,064  Apoptosis antagonist
0,336  0,066  Antihypertensive
0,339  0,069  Cholesterol antagonist
0,313  0,047  Antineoplastic (lymphoma)
0,298  0,032  Antihelmintic
0,317  0,052  Antihypoxic
0,335  0,070  Antithrombotic
0,284  0,020  Amylase inhibitor
0,351  0,090  Antipruritic, allergic
0,326  0,065  Antipsoriatic
0,311  0,053  NOS2 expression inhibitor
0,312  0,056  FMO3 substrate
0,258  0,004  GABA C receptor rho-1 antagonist
0,306  0,056  Antineoplastic (glioma)
0,332  0,082  Transcription factor NF kappa B inhibitor
0,266  0,018  Succinate dehydrogenase inhibitor
0,279  0,031  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,246  0,005  Carcinogenic, group 2A
0,266  0,025  Interferon gamma antagonist
0,284  0,045  Chemopreventive
0,252  0,015  5 Hydroxytryptamine 3E antagonist
0,260  0,023  3C-like protease (Human coronavirus) inhibitor
0,291  0,056  Antineoplastic (renal cancer)
0,308  0,074  Antineoplastic (brain cancer)
0,244  0,010  Microtubule formation inhibitor
0,240  0,010  Antirickettsial
0,257  0,027  Hair growth stimulant
0,269  0,040  RNA-directed DNA polymerase inhibitor
0,292  0,063  Antihypercholesterolemic
0,232  0,005  Interleukin 2 antagonist
0,306  0,079  CYP2D6 substrate
0,335  0,108  15-Lipoxygenase inhibitor
0,304  0,079  Antifungal
0,302  0,077  CYP3A4 inhibitor
0,280  0,059  Proliferative diseases treatment
0,282  0,064  Cardiotonic
0,249  0,033  Nitric-oxide synthase stimulant
0,296  0,080  Caspase 3 stimulant
0,225  0,010  Contraceptive female
0,234  0,019  Cell wall synthesis inhibitor
0,224  0,010  Antineoplastic, alkylator
0,261  0,049  Nitric oxide antagonist
0,212  0,005  Antihypermotility
0,227  0,021  ATPase inhibitor
0,238  0,032  Antiacne
0,210  0,005  Antidote, mercury
0,262  0,059  Antineoplastic (glioblastoma multiforme)
0,259  0,058  UGT1A6 substrate
0,221  0,021  DNA intercalator
0,272  0,072  UGT1A9 substrate
0,220  0,022  Cholesterol synthesis inhibitor
0,277  0,080  CYP1A2 substrate
0,250  0,055  Antiparkinsonian, rigidity relieving
0,328  0,133  Antiarthritic
0,212  0,018  Antieczematic
0,208  0,014  Beta amyloid protein antagonist
0,218  0,024  Phobic disorders treatment
0,239  0,049  Antiviral (West Nile virus)
0,207  0,017  UDP-glucose 4-epimerase inhibitor
0,276  0,086  Immunostimulant
0,212  0,023  Arachidonic acid antagonist
0,209  0,020  Ferrochelatase inhibitor
0,194  0,006  Interleukin 1 beta converting enzyme inhibitor
0,230  0,043  Antipruritic, non-allergic
0,241  0,054  Anesthetic general
0,218  0,034  Phospholipase A2 inhibitor
0,269  0,088  Lipoxygenase inhibitor
0,242  0,061  Antihypotensive
0,199  0,019  Histone deacetylase class III inhibitor
0,264  0,084  CYP2C19 substrate
0,183  0,006  Ca2+-transporting ATPase inhibitor
0,203  0,026  GST P1-1 substrate
0,191  0,015  Antispirochetal
0,222  0,047  Antimutagenic
0,192  0,018  Coagulant
0,202  0,027  DNA polymerase I inhibitor
0,191  0,017  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,205  0,032  Topoisomerase II inhibitor
0,292  0,119  Calpain 2 inhibitor
0,205  0,033  UGT2B10 substrate
0,231  0,059  Antialcoholic
0,178  0,007  Paget's disease treatment
0,172  0,004  Potassium channel Kv1.3 blocker
0,210  0,042  VEGF expression inhibitor
0,225  0,057  UGT1A1 substrate
0,200  0,032  Hemostatic
0,205  0,037  UGT2B9 substrate
0,172  0,007  Ornithine decarboxylase inhibitor
0,197  0,031  Histone deacetylase SIRT1 inhibitor
0,274  0,111  Vasodilator, coronary
0,214  0,052  UGT1A4 substrate
0,176  0,014  Triose-phosphate isomerase inhibitor
0,238  0,077  Vasodilator
0,197  0,037  Genotoxic
0,184  0,025  Antiviral (Poxvirus)
0,199  0,041  Melanin inhibitor
0,177  0,020  Catalase inhibitor
0,173  0,016  Hedgehog signaling inhibitor
0,243  0,087  Gastrin inhibitor
0,166  0,012  Acetylcholine M3 receptor agonist
0,154  0,005  Aldosterone antagonist
0,157  0,008  Histone deacetylase SIRT2 inhibitor
0,233  0,084  Antineoplastic (sarcoma)
0,240  0,092  Chemoprotective
0,168  0,021  Adenylate kinase inhibitor
0,233  0,086  Superoxide dismutase inhibitor
0,163  0,017  Actinic keratosis treatment
0,161  0,015  NADH dehydrogenase inhibitor
0,234  0,091  Interleukin agonist
0,239  0,096  Spasmolytic
0,150  0,007  Glycine receptor antagonist
0,187  0,045  Skeletal muscle relaxant
0,145  0,003  DNA gyrase subunit A inhibitor
0,148  0,008  ATPase (Vacuolar H+) inhibitor
0,151  0,010  Alcohol oxidase inhibitor
0,155  0,015  CYP2A6 inhibitor
0,165  0,026  Vanilloid 1 agonist
0,150  0,011  Carbamoyl phosphate synthetase inhibitor
0,155  0,018  Electrolyte absorption antagonist
0,154  0,016  Anabolic
0,192  0,055  UGT1A3 substrate
0,178  0,041  Antifungal enhancer
0,151  0,014  Keratolytic
0,226  0,090  Antineoplastic (non-small cell lung cancer)
0,148  0,012  Postmenopausal disorders treatment
0,155  0,020  Prolactin inhibitor
0,200  0,065  Hepatoprotectant
0,172  0,036  Antihyperlipoproteinemic
0,143  0,008  Caspase 7 inhibitor
0,153  0,018  Antifungal (Pneumocystis)
0,255  0,123  Vasodilator, peripheral
0,134  0,004  Anesthetic inhalation
0,156  0,026  DNA repair enzyme inhibitor
0,163  0,033  Antineoplastic antimetabolite
0,243  0,114  Hepatic disorders treatment
0,137  0,008  Granulocyte macrophage colony stimulating factor agonist
0,226  0,098  Antioxidant
0,136  0,008  Protein 50S ribosomal subunit inhibitor
0,179  0,052  UGT2B15 substrate
0,131  0,004  Phosphodiesterase VIII inhibitor
0,183  0,057  Aldehyde oxidase substrate
0,215  0,089  Antineoplastic (lymphocytic leukemia)
0,148  0,023  Androgen antagonist
0,229  0,105  Antineoplastic (melanoma)
0,133  0,009  Glycine receptor agonist
0,173  0,051  CNS active muscle relaxant
0,198  0,076  Insulin sensitizer
0,179  0,057  Antiviral (Herpes)
0,208  0,087  Potassium channel blocker
0,153  0,032  Antiprotozoal (Babesia)
0,125  0,004  Exportin-1 inhibitor
0,189  0,068  Antiviral (Hepatitis)
0,161  0,041  Aldehyde dehydrogenase inhibitor
0,187  0,067  UGT2B7 substrate
0,173  0,053  Antiparkinsonian, tremor relieving
0,160  0,041  Cyclooxygenase 3 inhibitor
0,145  0,026  Creatine kinase inhibitor
0,160  0,042  Alkylator
0,130  0,013  Premenstrual syndrome treatment
0,167  0,050  CF transmembrane conductance regulator agonist
0,192  0,075  Platelet adhesion inhibitor
0,166  0,050  SULT1A3 substrate
0,182  0,067  Muscle relaxant
0,173  0,058  Neurotensin receptor agonist
0,161  0,047  Adenylate cyclase stimulant
0,145  0,032  Antineoplastic antibiotic
0,222  0,109  Radioprotector
0,214  0,101  Calpain inhibitor
0,118  0,005  Antidote, organophosphates
0,126  0,013  Na+ K+ transporting ATPase inhibitor
0,221  0,110  Transcription factor STAT3 inhibitor
0,221  0,110  Transcription factor STAT inhibitor
0,161  0,050  Hearing loss treatment
0,113  0,004  Glucose-6-phosphate isomerase inhibitor
0,139  0,031  Chronic obstructive bronchitis treatment
0,133  0,024  Porphobilinogen synthase inhibitor
0,149  0,041  Cystathionine beta-synthase inhibitor
0,230  0,122  CYP2D6 inhibitor
0,164  0,059  Pulmonary hypertension treatment
0,140  0,035  Antihelmintic (Fasciola)
0,128  0,023  Interleukin 12 antagonist
0,168  0,064  Uterine stimulant
0,143  0,040  MAO B inhibitor
0,150  0,046  Cathepsin H inhibitor
0,159  0,056  MAO inhibitor
0,116  0,013  Acyl-CoA dehydrogenase inhibitor
0,127  0,024  Glutamate (mGluR7) agonist
0,149  0,047  Heat shock protein 70 antagonist
0,167  0,065  Urolithiasis treatment
0,129  0,027  UGT2B11 substrate
0,174  0,073  Tumour necrosis factor antagonist
0,126  0,026  Tourette's syndrome treatment
0,168  0,070  Antihelmintic (Nematodes)
0,132  0,034  DOPA decarboxylase inhibitor
0,222  0,127  Insulysin inhibitor
0,137  0,041  TRPA1 agonist
0,105  0,010  Antiviral (Parainfluenza)
0,138  0,043  Aminopeptidase B inhibitor
0,112  0,018  Protein kinase C alpha inhibitor
0,120  0,027  Antibiotic
0,108  0,016  Acetylcholine M5 receptor agonist
0,116  0,024  Glutamate dehydrogenase inhibitor
0,121  0,029  Lanosterol 14 alpha demethylase inhibitor
0,158  0,066  Aldose reductase substrate
0,163  0,073  Antiviral (Hepatitis C)
0,107  0,017  Biliverdin reductase inhibitor
0,128  0,039  Carbonic anhydrase III inhibitor
0,133  0,044  Mucolytic
0,103  0,014  Androgen agonist
0,133  0,045  Antiviral (Influenza B)
0,132  0,044  Photosensitizer
0,216  0,128  Antiischemic
0,132  0,044  Protein kinase C gamma inhibitor
0,135  0,047  Glutathione S-transferase substrate
0,100  0,013  Antimycoplasmal
0,096  0,009  Aconitate hydratase inhibitor
0,098  0,012  Glutamate (mGluR6) antagonist
0,092  0,007  RNA-directed RNA polymerase stimulant
0,109  0,024  mTOR complex 2 inhibitor
0,160  0,076  Prostate disorders treatment
0,103  0,018  Argininosuccinate synthase inhibitor
0,098  0,015  Protein kinase C beta inhibitor
0,145  0,063  Pregnane X receptor agonist
0,190  0,109  Platelet antagonist
0,135  0,054  Gastritis treatment
0,168  0,087  LDLR expression enhancer
0,106  0,026  Glutamate decarboxylase inhibitor
0,089  0,009  Potassium channel (Inward rectifier) blocker
0,082  0,004  Sodium-dependent vitamin C transporter 2 inhibitor
0,110  0,033  Restless leg syndrome treatment
0,091  0,014  SULT2A1 substrate
0,173  0,097  Psychostimulant
0,078  0,004  Tubulin agonist
0,132  0,059  Anesthetic local
0,104  0,030  Histidine decarboxylase inhibitor
0,119  0,047  Antiprotozoal (Toxoplasma)
0,084  0,012  Nicotinic alpha3beta2 receptor antagonist
0,160  0,088  Phospholipase C inhibitor
0,075  0,004  Guanylate cyclase inhibitor
0,093  0,022  Anticholelithogenic
0,100  0,029  Interferon agonist
0,097  0,027  Phenylalanine 4-hydroxylase inhibitor
0,075  0,005  Microtubule stabilization
0,130  0,060  Adenylate cyclase inhibitor
0,087  0,017  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,127  0,060  Proteasome inhibitor
0,178  0,112  Fibrosis treatment
0,118  0,052  Expectorant
0,077  0,012  Alpha-mannosidase inhibitor
0,086  0,022  Protease 3C (Human rhinovirus) inhibitor
0,167  0,103  CYP2B6 inhibitor
0,121  0,058  Caspase 3 inhibitor
0,094  0,031  Aminopeptidase I inhibitor
0,066  0,004  HMG CoA reductase inhibitor
0,080  0,018  Potassium channel intermediate-conductance Ca-activated blocker
0,074  0,012  Progesterone antagonist
0,103  0,042  Bile acid receptor antagonist
0,113  0,052  Carbonic anhydrase XV inhibitor
0,126  0,067  Antiviral (Papilloma)
0,098  0,039  Glutathione S-transferase inhibitor
0,062  0,003  Potassium channel (Inward rectifier) 1 blocker
0,081  0,023  Interferon inducer
0,078  0,021  Phosphodiesterase 1C inhibitor
0,092  0,035  Transforming growth factor beta 3 antagonist
0,138  0,082  Thiol protease inhibitor
0,135  0,079  Mannose-6-phosphate isomerase inhibitor
0,105  0,050  HIV-1 integrase (Overall Integration) inhibitor
0,093  0,037  Nicotinic alpha4beta2 receptor antagonist
0,097  0,042  Topoisomerase II alpha inhibitor
0,063  0,008  Caspase 2 inhibitor
0,064  0,009  Antihyperaldosteronism
0,092  0,037  Estrogen-related receptor beta agonist
0,099  0,045  Glutamate release inhibitor
0,138  0,084  Antidote
0,163  0,110  Cardiodepressant
0,060  0,008  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,156  0,104  Antineoplastic (bone cancer)
0,093  0,042  Sodium/hydrogen exchanger 5 inhibitor
0,064  0,014  Mannosidase inhibitor
0,081  0,031  Potassium channel (Tandem pore domain) blocker
0,111  0,061  Choleretic
0,098  0,049  Calcium antagonist
0,080  0,031  Endocannabinoid uptake inhibitor
0,071  0,023  Phosphodiesterase 1A inhibitor
0,111  0,063  5 Hydroxytryptamine 3A agonist
0,190  0,142  5 Hydroxytryptamine 1E antagonist
0,113  0,066  Monophenol monooxygenase inhibitor
0,057  0,010  Sirtuin 2 inhibitor
0,086  0,039  GABA aminotransferase inhibitor
0,062  0,016  Cholesterol esterase inhibitor
0,120  0,074  Antiseptic
0,111  0,065  SULT1A1 substrate
0,081  0,035  Secretase beta inhibitor
0,122  0,076  Toll-Like receptor 2 antagonist
0,098  0,053  Antiviral (Rhinovirus)
0,066  0,021  Dihydroorotate oxidase inhibitor
0,061  0,018  Potassium channel (Inward rectifier) activator
0,062  0,019  Squalene epoxidase inhibitor
0,087  0,045  Carbonic anhydrase XIII inhibitor
0,080  0,039  Prokinetic
0,051  0,011  Glutamate (mGluR8) agonist
0,058  0,018  Potassium channel (ATP-sensitive) activator
0,056  0,017  Glutamate (mGluR1a) antagonist
0,080  0,040  Vanilloid 4 agonist
0,067  0,027  Ornithine carbamoyltransferase inhibitor
0,050  0,011  Acetylcholine M4 receptor agonist
0,051  0,013  Kainate receptor agonist
0,051  0,013  Fumarate hydratase inhibitor
0,050  0,012  Integrin alpha2 antagonist
0,070  0,032  Purinergic P2X1 antagonist
0,111  0,074  Menstruation disorders treatment
0,074  0,036  Glutamate (mGluR7) antagonist
0,081  0,044  NAT1 substrate
0,069  0,032  Phosphodiesterase 1B inhibitor
0,194  0,158  NOS3 expression inhibitor
0,059  0,023  Topoisomerase II beta inhibitor
0,149  0,115  Antiviral (Influenza)
0,107  0,073  Acetylcholine release stimulant
0,099  0,065  mTOR complex 1 inhibitor
0,080  0,047  MAP kinase kinase 7 inhibitor
0,111  0,078  Transcription factor STAT6 inhibitor
0,117  0,084  Cyclooxygenase 1 inhibitor
0,064  0,031  Fatty acid synthase inhibitor
0,132  0,100  Raynaud's phenomenon treatment
0,090  0,058  Phosphodiesterase I inhibitor
0,050  0,019  5-Alpha-reductase inhibitor
0,080  0,049  Estrogen receptor alpha antagonist
0,053  0,023  Adenylate cyclase 1 inhibitor
0,060  0,030  Pregnane X receptor antagonist
0,059  0,029  Nicotinic receptor alpha7 subunit antagonist
0,100  0,071  UGT2B1 substrate
0,037  0,007  Integrin alpha2beta1 antagonist
0,072  0,043  Sphingosine 1-phosphate receptor 4 agonist
0,062  0,032  Ryanodine receptor antagonist
0,099  0,071  AMP-activated protein kinase stimulant
0,066  0,037  Aromatase inhibitor
0,039  0,012  Uridine phosphorylase inhibitor
0,185  0,158  Antineoplastic (bladder cancer)
0,054  0,028  Antibiotic Glycopeptide-like
0,046  0,020  Membrane dipeptidase inhibitor
0,068  0,042  Uterine relaxant
0,160  0,134  Antiamyloidogenic
0,060  0,035  Postcoital contraceptive
0,086  0,061  Tocolytic
0,068  0,043  Antihemophilic
0,051  0,027  Cytokine production stimulant
0,044  0,019  Cholesterol absorption inhibitor
0,063  0,040  Narcolepsy treatment
0,051  0,028  Dopamine beta hydroxylase inhibitor
0,052  0,029  HCV NS3/NS4A protease inhibitor
0,032  0,010  Nicotinic acid receptor 2 antagonist
0,106  0,084  Mental retardation treatment
0,044  0,022  Dopamine D5 agonist
0,030  0,008  GRP78 expression inhibitor
0,045  0,023  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,128  0,107  Hexokinase inhibitor
0,039  0,018  ATM kinase inhibitor
0,123  0,102  Antiprotozoal (Coccidial)
0,092  0,071  Dementia treatment
0,055  0,034  Elastase inhibitor
0,057  0,036  Acetylcholine muscarinic agonist
0,090  0,069  Vascular dementia treatment
0,029  0,009  Inosine monophosphate dehydrogenase 1 inhibitor
0,180  0,160  Renal disease treatment
0,127  0,108  Sphingosine 1-phosphate receptor 5 antagonist
0,072  0,054  S-adenosyl-L-methionine decarboxylase inhibitor
0,063  0,044  5 Hydroxytryptamine 2A agonist
0,090  0,072  Xanthine oxidase inhibitor
0,035  0,017  Glutamate (mGluR3) agonist
0,036  0,019  Melatonin 2 agonist
0,051  0,034  Lysophosphatidic acid 3 receptor antagonist
0,109  0,092  Anesthetic
0,041  0,024  GABA uptake inhibitor
0,029  0,011  Vanilloid 2 agonist
0,029  0,012  Lysophosphatidic acid receptor 1 agonist
0,040  0,023  Arginase inhibitor
0,052  0,035  5 Hydroxytryptamine 4 antagonist
0,031  0,015  Purinergic P2Y15 antagonist
0,039  0,023  Inosine monophosphate dehydrogenase inhibitor
0,045  0,029  Acetylcholine M1 receptor agonist
0,093  0,078  Mediator release inhibitor
0,059  0,043  Cannabinoid CB1 receptor agonist
0,032  0,017  Caspase 6 inhibitor
0,070  0,054  Phospholipase D inhibitor
0,021  0,006  Telomerase stimulant
0,022  0,007  Carbonic anhydrase X inhibitor
0,022  0,007  Carbonic anhydrase VIII inhibitor
0,073  0,058  GABA B receptor agonist
0,023  0,009  Cyclin T1 inhibitor
0,072  0,058  NAD(P)H dehydrogenase (quinone) inhibitor
0,103  0,090  Antiviral (Hepatitis B)
0,036  0,024  Nicotinic acid receptor agonist
0,021  0,009  Antibiotic Anthracycline-like
0,021  0,010  Progesterone agonist
0,043  0,032  Nicotinic receptor alpha3 subunit antagonist
0,018  0,006  Lysophosphatidic acid receptor 3 agonist
0,097  0,086  Antifungal (Aspergillus)
0,019  0,009  Vesicular glutamate transport inhibitor
0,027  0,017  Sodium/glucose cotransporter 2 inhibitor
0,161  0,151  Antiviral (Ebola)
0,018  0,008  Antibiotic Macrolide-like
0,152  0,142  Free radical scavenger
0,021  0,012  5-Alpha-reductase 2 inhibitor
0,034  0,025  Phosphoglycerate kinase inhibitor
0,104  0,094  Shock treatment
0,042  0,033  Heme oxygenase inhibitor
0,073  0,064  Acetylcholine nicotinic antagonist
0,058  0,048  NMDA receptor glycine site agonist
0,023  0,015  Prostaglandin F2 alpha agonist
0,034  0,026  Retinoid X receptor agonist
0,019  0,011  Methylmalonyl-CoA mutase inhibitor
0,025  0,017  Sodium/glucose cotransporter 1 inhibitor
0,026  0,018  Sodium/glucose cotransporter inhibitor
0,011  0,003  Antibiotic Penem-like
0,036  0,029  Delayed rectifier potassium channel blocker
0,050  0,043  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,039  0,032  Estradiol 17 beta-dehydrogenase inhibitor
0,027  0,020  Hypoxanthine phosphoribosyltransferase inhibitor
0,061  0,054  Calcium channel P-type blocker
0,058  0,052  DNA gyrase inhibitor
0,071  0,065  Macrophage migration inhibitory factor inhibitor
0,040  0,034  Leukocyte elastase inhibitor
0,019  0,014  Inosine monophosphate dehydrogenase 2 inhibitor
0,032  0,027  Retinoid X alpha receptor agonist
0,021  0,016  Glutamate (mGluR1a) agonist
0,052  0,047  Glutamate (mGluR1) antagonist
0,125  0,120  MAP kinase 3 inhibitor
0,032  0,027  Melatonin receptor 1A agonist
0,072  0,068  Carbonic anhydrase VI inhibitor
0,108  0,104  Cocaine dependence treatment
0,019  0,015  Antibiotic Quinolone-like
0,044  0,040  Metalloproteinase-3 inhibitor
0,015  0,011  Purinergic P2Y1 agonist
0,059  0,056  Neuronal nicotinic receptor antagonist
0,012  0,009  Glutamate (mGluR6) agonist
0,045  0,043  Antiviral (Herpesvirus 3, Human)
0,029  0,027  ATP citrate lysase inhibitor
0,078  0,076  D-Ala-D-Ala ligase inhibitor
0,015  0,013  5-Alpha-reductase 1 inhibitor
0,104  0,102  Antiprotozoal (Amoeba)
0,050  0,049  Epithelial sodium channel blocker
0,026  0,024  Hedgehog signaling activator
0,033  0,032  Tryptophan 5 hydroxylase inhibitor
0,070  0,068  Narcotic antagonist
0,085  0,084  NAT2 substrate
0,018  0,017  Hexokinase stimulant
0,014  0,014  Thromboxane A2 agonist
0,034  0,034  Retinoid X receptor antagonist
0,014  0,014  Prostacyclin agonist

